Head of Medicine at NUI Galway
A message from the Director
REMEDI’s vision is to develop a new and realizable paradigm for medicine in the future utilizing minimally invasive therapeutic approaches to promote organ and tissue repair and regeneration thus avoiding the need for replacement. To achieve this, the REMEDI translational research programme has a mission to conduct basic research in fundamental stem cell biology and to translate and commercialise research outputs by developing regenerative medicine therapies for diseases such as; cardiovascular disease, diabetes mellitus and osteoarthritis.
Supporting the realization of our vision are the strategic partnerships REMEDI has forged with academics, the health service and industry. As REMEDI enters the second, exciting phase of its development following renewed funding from Science Foundation Ireland, its focus will shift to translating the basic research findings from the initial exploratory phase of REMEDI to clinical trial applications – to effectively progress from research to human therapy.
This new phase in the existence of REMEDI will allow Irish patients access to novel therapies through state-of-the-art clinical trials and research. It will allow REMEDI to build on its existing partnerships with Irish companies operating in the medical technology area, to further develop a global hub of medical device technology in Ireland.
The Regenerative Medicine Institute was established at NUI Galway and partner academic institutions in 2004 with funding obtained from Science Foundation Ireland.
follow us on Twitter @remedinuig
